Non-invasive blood glucose monitoring: emerging HealthTech sub sector is 'one to watch in 2024'
Lloyd Price
SEPTEMBER 12, 2023
The growth of the NGBGM market is expected to drive M&A activity in the healthtech sub sector in 2024. Companies that are developing new NGBGM technologies or that are looking to expand their reach in the market are expected to be active in M&A deals. The company is likely to be a target for acquisition by a larger company.
Let's personalize your content